April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Macular Morphological and Functional Evaluation in Italian Patients with Stargardt Disease
Author Affiliations & Notes
  • Michele Della Corte
    Eye Clinic, University of Naples, Naples, Italy
  • Settimio Rossi
    Eye Clinic, University of Naples, Naples, Italy
  • Francesco Testa
    Eye Clinic, University of Naples, Naples, Italy
  • Andrea Sodi
    Eye Clinic, University of Florence, Florence, Italy, Florence, Italy
  • Enrico Maria Surace
    Telethon Institute of Genetics and Medicine, Naples, Italy
  • Ilaria Passerini
    Department of Genetic Diagnosis, Careggi Universitary Hospital, Florence, Italy
  • Valentina Di Iorio
    Eye Clinic, University of Naples, Naples, Italy
  • Ugo Menchini
    Eye Clinic, University of Florence, Florence, Italy, Florence, Italy
  • Alberto Auricchio
    Telethon Institute of Genetics and Medicine, Naples, Italy
  • Francesca Simonelli
    Eye Clinic, University of Naples, Naples, Italy
  • Footnotes
    Commercial Relationships  Michele Della Corte, None; Settimio Rossi, None; Francesco Testa, None; Andrea Sodi, None; Enrico Maria Surace, None; Ilaria Passerini, None; Valentina Di Iorio, None; Ugo Menchini, None; Alberto Auricchio, None; Francesca Simonelli, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5016. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michele Della Corte, Settimio Rossi, Francesco Testa, Andrea Sodi, Enrico Maria Surace, Ilaria Passerini, Valentina Di Iorio, Ugo Menchini, Alberto Auricchio, Francesca Simonelli; Macular Morphological and Functional Evaluation in Italian Patients with Stargardt Disease. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5016.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Autosomal recessive Stargardt disease (STGD) has been associated with substantial genetic and phenotypic heterogeneity. By systematic clinical analyses of STGD patients with complete genetic data (i.e., identified mutations on both alleles of the ABCA4 gene), we set out to determine the range of disease expression in the macula and to correlate these with specific ABCA4 alleles.

Methods: : 86 patients from 64 families with STGD/fundus flavimaculatus were investigated. All patients were submitted to complete ophthalmologic examination, optical coherence tomography, microperimetry, electroretinogram, multifocal ERG and ABCA4 gene analysis.

Results: : Two main disease expressions were observed among the examined patients. Severe macular disease group had mean visual acuity of 0.1 ± 0.05, mean foveal thickness 137.8 ± 10.4 µm, mean retinal sensitivities of 0,7 ± 0.4 dB, abnormal ERG response, mfERG within noise level in all six macular rings and no is/os layer visible at OCT examination. Mild macular disease group had mean visual acuity of 0.3 ± 0.06, mean foveal thickness 143.5 ± 6.86 µm, and mean retinal sensitivities 12.63 ± 1.1 dB, normal ERG response and multifocal ERG response for ring 1 and 2 within noise level while the response density in the most peripheral eccentricity was only slightly smaller than that measured in the control groups. The OCT revealed a preserved IS/OS in extra foveal region in 19 out of 21 patients. A significant difference between the two groups was observed in relation to visual acuity (P<0.05), retinal sensitivities (P< 0.001), preserved IS/OS (P< 0.001). mfERG was recordable in the mild group and extinguished in all patients of the severe macular group. Genetic analysis of the ABCA4 gene revealed, in the severe group, more frequent deletions, stop codons and insertions as compared to the mild phenotype group (p <0.05).

Conclusions: : This study documented morphological and functional variability of the clinical expression of STGD and allowed to distinguish different classes of disease severity, partially correlated to the genotype, allowing a better defined prognosis. These findings suggest criteria for identifying appropriate candidates with specific ABCA4 variants for upcoming human gene therapy trials in ABCA4 disease.

Keywords: macula/fovea • pathology: human • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×